Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes



Rating:

Share or cite this content

Citations should be made in the following way:
G. Iturricastillo (MADRID, Spain), E. Martínez (MADRID, Spain), J. Eiros (MADRID, Spain), P. Landete (MADRID, Spain), E. Ávalos (MADRID, Spain), C. Cisneros (MADRID, Spain), J. Ancochea (MADRID, Spain). The effect of CPAP in asthma patients with SAHS. 3579

Member's Comments

No comment yet.

Related content which might interest you: Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 CPAP setting prediction in OSAS patients Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011 CPAP increases bronchial reactivity in OSAS patients Source: Eur Respir Rev 2008; 17: 101-102 Year: 2008 CPAP increases bronchial reactivity in OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005 Effect of CPAP adherence on depression in OSA patient Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020 Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Impact of CPAP on asthmatic patients with obstructive sleep apnoea Source: Eur Respir J 2007; 29: 307-311 Year: 2007 Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Effects of CPAP treatment on anxiety and depression in patients with OSAS Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 CPAP and measures of cardiovascular risks in patients with OSAS Source: Eur Respir J 2009; 33: 1520 Year: 2009 Automatic CPAP performance in sleep apnea patients with associated COPD Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 The prevalence of obstructive sleep apnea (OSA) in patients with severe asthma and the association between severity of OSA and asthma control Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007 Insomnia, OSAS and CPAP treatment Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 The impact of OSA on nocturnal hypoxia in obese patients with chronic asthma Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012 Treatment of early undiagnosed airflow obstruction in patients of OSA on CPAP improves sleep quality and symptoms Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes Year: 2021 A comparison of two different autotitrating CPAP devices and constant CPAP in patients with obstructive sleep apnoea Source: Eur Respir J 2003; 22: Suppl. 45, 94s Year: 2003 The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 216s Year: 2006